Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rik Ossenkoppele

Showing results (131-140 of 310) with videos related to

Pageof 31
Sort By:
Nature Communications|April 9, 2026
Trajectories of plasma and CSF MTBR-tau243 and phosphorylated-tau species across the Alzheimer's disease continuumLyduine E Collij, Gemma Salvadó, Kanta Horie, et al.
Alzheimer'S Research & Therapy|September 1, 2022
Rationale and design of the "NEurodegeneration: Traumatic brain injury as Origin of the Neuropathology (NEwTON)" study: a prospective cohort study of individuals at risk for chronic traumatic encephalopathySuzan van Amerongen, Dewi K Caton, Rik Ossenkoppele, et al.
JAMA Neurology|May 19, 2025
Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer DiseaseAlexa Pichet Binette, Ruben Smith, Gemma Salvadó, et al.
European Radiology|April 5, 2017
Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PETDavid Fällmar, Sven Haller, Johan Lilja, et al.
International Journal of Geriatric Psychiatry|June 15, 2022
Biweekly fluctuations of neuropsychiatric symptoms according to the Neuropsychiatric Inventory: Erratic symptoms or scores?Willem S Eikelboom, Amy den Teuling, Daphne E Pol, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2021
A multicenter comparison of [<sup>18</sup>F]flortaucipir, [<sup>18</sup>F]RO948, and [<sup>18</sup>F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosisAntoine Leuzy, Tharick A Pascoal, Olof Strandberg, et al.
JAMA Neurology|December 4, 2023
Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid ImmunotherapiesNiklas Mattsson-Carlgren, Lyduine E Collij, Erik Stomrud, et al.
Science Advances|May 20, 2020
Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's diseaseNiklas Mattsson-Carlgren, Emelie Andersson, Shorena Janelidze, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2012
Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PETRik Ossenkoppele, Nelleke Tolboom, Jessica C Foster-Dingley, et al.
Medrxiv : the Preprint Server for Health Sciences|August 13, 2025
Proteomic signatures of the <i>APOE ε4</i> and <i>APOE ε2</i> genetic variants and Alzheimer's diseaseLina Lu, Alexa Pichet Binette, Ines Hristovska, et al.
Pageof 31

Showing results (131-140 of 310) with videos related to

Sort By:
Pageof 31
Nature Communications|April 9, 2026
Trajectories of plasma and CSF MTBR-tau243 and phosphorylated-tau species across the Alzheimer's disease continuumLyduine E Collij, Gemma Salvadó, Kanta Horie, et al.
Alzheimer'S Research & Therapy|September 1, 2022
Rationale and design of the "NEurodegeneration: Traumatic brain injury as Origin of the Neuropathology (NEwTON)" study: a prospective cohort study of individuals at risk for chronic traumatic encephalopathySuzan van Amerongen, Dewi K Caton, Rik Ossenkoppele, et al.
JAMA Neurology|May 19, 2025
Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer DiseaseAlexa Pichet Binette, Ruben Smith, Gemma Salvadó, et al.
European Radiology|April 5, 2017
Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PETDavid Fällmar, Sven Haller, Johan Lilja, et al.
International Journal of Geriatric Psychiatry|June 15, 2022
Biweekly fluctuations of neuropsychiatric symptoms according to the Neuropsychiatric Inventory: Erratic symptoms or scores?Willem S Eikelboom, Amy den Teuling, Daphne E Pol, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2021
A multicenter comparison of [<sup>18</sup>F]flortaucipir, [<sup>18</sup>F]RO948, and [<sup>18</sup>F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosisAntoine Leuzy, Tharick A Pascoal, Olof Strandberg, et al.
JAMA Neurology|December 4, 2023
Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid ImmunotherapiesNiklas Mattsson-Carlgren, Lyduine E Collij, Erik Stomrud, et al.
Science Advances|May 20, 2020
Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's diseaseNiklas Mattsson-Carlgren, Emelie Andersson, Shorena Janelidze, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2012
Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PETRik Ossenkoppele, Nelleke Tolboom, Jessica C Foster-Dingley, et al.
Medrxiv : the Preprint Server for Health Sciences|August 13, 2025
Proteomic signatures of the <i>APOE ε4</i> and <i>APOE ε2</i> genetic variants and Alzheimer's diseaseLina Lu, Alexa Pichet Binette, Ines Hristovska, et al.
Pageof 31